These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16430066)

  • 1. Chemotherapy for endometrial carcinoma.
    Gebbia V; Agueli R
    Tunis Med; 2005 Dec; 83 Suppl 12():34-5. PubMed ID: 16430066
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there any place for cytotoxic chemotherapy in endometrial cancer?
    Steer C; Harper P
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):447-67. PubMed ID: 11476565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for early stage endometrial cancer? Should we be using it?
    Rodriguez AO
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):1-3. PubMed ID: 18196997
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of advanced-stage and recurrent endometrial cancer.
    Ray M; Fleming G
    Semin Oncol; 2009 Apr; 36(2):145-54. PubMed ID: 19332249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
    Dellinger TH; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs in endometrial cancers.
    Altundag O; Dursun P; Ayhan A
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):557-68. PubMed ID: 20828226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model.
    Mountzios G; Bamias A; Voulgaris Z; Rodolakis A; Vlahos G; Gourgoulis G; Papaiakovou EE; Giannopoulos A
    Gynecol Oncol; 2008 Jan; 108(1):130-5. PubMed ID: 17988722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment of early-stage endometrial cancer: which patient can benefit from chemotherapy?
    Eichbaum MH; Sohn C
    Gynecol Oncol; 2008 Jun; 109(3):434; author reply 434-6. PubMed ID: 18295870
    [No Abstract]   [Full Text] [Related]  

  • 10. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH;
    Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
    Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of chemotherapy in recurrent endometrial carcinoma].
    Wang ZQ; Wang JL; Liu FT; Zhao D; Gao M; Wei LH
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):896-900. PubMed ID: 16759515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
    Wang HY; Shen L; Sun Z
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D; Xiros N; Papaxoinis G; Pectasides E; Sykiotis C; Koumarianou A; Psyrri A; Gaglia A; Kassanos D; Gouveris P; Panayiotidis J; Fountzilas G; Economopoulos T
    Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma.
    Elizur SE; Beiner ME; Korach J; Weiser A; Ben-Baruch G; Dor J
    Fertil Steril; 2007 Dec; 88(6):1562-7. PubMed ID: 17412340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
    Hogberg T
    Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A successful live twin birth by in vitro fertilization after conservative treatment of recurrent endometrial cancer.
    Wu HM; Lai CH; Huang HY; Wang HS; Soong YK
    Chang Gung Med J; 2008; 31(1):102-6. PubMed ID: 18419059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide in the treatment of platinum-resistant recurrent endometrial cancer: a case report and literature review.
    Cai H; Li X; Wang J
    J Obstet Gynaecol; 2020 Jan; 40(1):137-138. PubMed ID: 31210078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.